Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashkan Emadi

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Molecular Carcinogenesis|December 23, 2022
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formationGautam Adhikary, Suruchi Shrestha, Warren Naselsky, et al.
International Journal of Molecular Sciences|December 17, 2024
Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid LeukemiaDominique Bollino, Xinrong Ma, Kayla M Tighe, et al.
Leukemia Research|May 19, 2015
Perturbation of cellular oxidative state induced by dichloroacetate and arsenic trioxide for treatment of acute myeloid leukemiaAshkan Emadi, Mariola Sadowska, Brandon Carter-Cooper, et al.
JAMA|June 18, 2009
Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic reviewJodi B Segal, Daniel J Brotman, Alejandro J Necochea, et al.
Evidence Report/Technology Assessment|July 16, 2010
Outcomes of genetic testing in adults with a history of venous thromboembolismJodi B Segal, Daniel J Brotman, Ashkan Emadi, et al.
Leukemia & Lymphoma|May 11, 2021
Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)Meagan A Jacoby, Laura Finn, Ashkan Emadi, et al.
Leukemia & Lymphoma|November 8, 2014
Treatment of catheter-related deep vein thrombosis in patients with acute leukemia with anticoagulationNora Oliver, Briana Short, Mya Thein, et al.
American Journal of Hematology|February 18, 2010
Analytic validity of genetic tests to identify factor V Leiden and prothrombin G20210AAshkan Emadi, Matthew T Crim, Daniel J Brotman, et al.
Frontiers in Oncology|December 29, 2022
Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycineDominique Bollino, J Preston Claiborne, Kanwal Hameed, et al.
Cancer Genetics|December 3, 2014
High frequency of rare structural chromosome abnormalities at relapse of cytogenetically normal acute myeloid leukemia with FLT3 internal tandem duplicationTheodore S Gourdin, Ying Zou, Yi Ning, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Molecular Carcinogenesis|December 23, 2022
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formationGautam Adhikary, Suruchi Shrestha, Warren Naselsky, et al.
International Journal of Molecular Sciences|December 17, 2024
Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid LeukemiaDominique Bollino, Xinrong Ma, Kayla M Tighe, et al.
Leukemia Research|May 19, 2015
Perturbation of cellular oxidative state induced by dichloroacetate and arsenic trioxide for treatment of acute myeloid leukemiaAshkan Emadi, Mariola Sadowska, Brandon Carter-Cooper, et al.
JAMA|June 18, 2009
Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic reviewJodi B Segal, Daniel J Brotman, Alejandro J Necochea, et al.
Evidence Report/Technology Assessment|July 16, 2010
Outcomes of genetic testing in adults with a history of venous thromboembolismJodi B Segal, Daniel J Brotman, Ashkan Emadi, et al.
Leukemia & Lymphoma|May 11, 2021
Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)Meagan A Jacoby, Laura Finn, Ashkan Emadi, et al.
Leukemia & Lymphoma|November 8, 2014
Treatment of catheter-related deep vein thrombosis in patients with acute leukemia with anticoagulationNora Oliver, Briana Short, Mya Thein, et al.
American Journal of Hematology|February 18, 2010
Analytic validity of genetic tests to identify factor V Leiden and prothrombin G20210AAshkan Emadi, Matthew T Crim, Daniel J Brotman, et al.
Frontiers in Oncology|December 29, 2022
Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycineDominique Bollino, J Preston Claiborne, Kanwal Hameed, et al.
Cancer Genetics|December 3, 2014
High frequency of rare structural chromosome abnormalities at relapse of cytogenetically normal acute myeloid leukemia with FLT3 internal tandem duplicationTheodore S Gourdin, Ying Zou, Yi Ning, et al.
Pageof 12